acute lung injury

NEW YORK, August 6, 2026 MiNK Therapeutics announced that it will report its second-quarter 2026 financial results before U.S....

NEW YORK, May 15, 2026 MiNK Therapeutics, Inc. reported first quarter 2026 financial results while highlighting major clinical and...